Please login to the form below

Not currently logged in
Email:
Password:

EASD 2013

This page shows the latest EASD 2013 news and features for those working in and with pharma, biotech and healthcare.

Novo backs Victoza's prospects in Alzheimer's

Novo backs Victoza's prospects in Alzheimer's

Speaking to PMLiVE at the European Association for the Study of Diabetes' (EASD) 2013 meeting in Barcelona last week, Novo's chief science officer Mads Krogsgaard Thomsen confirmed the drug, approved ... the end of 2013.

Latest news

More from news
Approximately 4 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics